Cytokine Release Syndrome
📧 Sign up to get email alerts when something new happens for Cytokine Release Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Jafron Haemoadsorption During Cardiopulmonary Bypass [Phase 2]
Phase 2 clinical trial update for Jafron haemoadsorption during cardiopulmonary bypass in patients with Cytokine Release Syndrome has comple…
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19 [Phase 3]
Phase 3 clinical trial update for PROlectin M, an antagonist targeting nucleocapsid terminal region, in COVID-19; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS [Phase 2]
Phase 2 trial evaluating therapeutic plasma exchange alone or with ruxolitinib for COVID-19-associated cytokine release syndrome; study comp…
-
FDA approval · 2021-10-22FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Actemra (tocilizumab) from Genentech, expanding its labeling and/or indications. The action conf…
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Efficacy and Safety of Itolizumab in COVID-19 Complications [Phase 2]
Phase 2 trial update on Itolizumab for COVID-19 complications reports efficacy and safety data.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating tocilizumab to prevent cytokine release syndrome after haploidentical stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome [Phase 2]
Phase 2 trial evaluating Day 0 cyclosporine as prophylaxis for cytokine release syndrome in stem cell transplant settings.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers [Phase 3]
Phase 3 clinical trial update assessing safety and efficacy of tocilizumab in moderate to severe COVID-19 with inflammatory markers; study t…
-
FDA approval · 2017-05-22FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. The supplementary filing status is AP (approv…
-
FDA approval · 2014-11-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. This action involves an approved product …
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Peri-operative Prediction of Prolonged Stay in the Cardiac Intensive Care Unit for Adult Cardiac Surgery
This clinical trial update reports on the completion of a study aimed at predicting which adult cardiac surgery patients may have a prolonge…
-
FDA approval · 2012-08-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Actemra (tocilizumab) submitted by Genentech, broadening its labeling.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery
This clinical trial update describes a study using a clinical scoring system and cytokine measurements to predict inflammatory response afte…